27 min listen
Optimizing Anticancer Therapy in Prostate Cancer Guideline
FromASCO Guidelines
ratings:
Length:
18 minutes
Released:
Apr 2, 2018
Format:
Podcast episode
Description
An interview with Dr. Michael J. Morris from Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine on the ASCO clinical practice guideline which addresses abiraterone or docetaxel with androgen-deprivation therapy (ADT) for metastatic prostate cancer that has not been treated (or has been minimally treated) with testosterone-lowering agents. Read the full guideline at www.asco.org/genitourinary-cancer-guidelines
Released:
Apr 2, 2018
Format:
Podcast episode
Titles in the series (100)
Practical Assessment and Management of Vulnerabilities in Older Patients Guideline: An interview with Dr. Supriya Mohile from University of Rochester on the guideline published in JCO which provides guidance regarding the practical assessment and management of vulnerabilities in older patients undergoing chemotherapy. To read... by ASCO Guidelines